Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of nintedanib in Japan
jRCT2080223925Phase 3Completed
- Start
- Jun 2018
- Modality
- Small Molecules
01
Overview
Phase 3 trial of nintedanib (2 arms). Started Jun 2018; status: completed.
02
Drugs
nintedanib
Beyond the preview
Go deeper on jRCT2080223925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223925.